-
1.发明授权公开(公告)号：US10675476B2
公开(公告)日：2020-06-09
申请号：US15847435
申请日：2017-12-19
摘要： Implantable medical device systems and methods of use including an implantable first medical device having a lead with a transducer thereon and an implantable second medical device having a receiver for receiving energy emitted by the transducer. The lead may be placed in an internal thoracic vein, and other locations may be used as well. The implantable second medical device may be placed in or on the heart or an associated blood vessel.
-
2.发明申请SYSTEMS AND METHODS TO REDUCE SYNCOPE RISK DURING NEURAL STIMULATION THERAPY 有权在神经刺激治疗期间减少同期风险的系统和方法公开(公告)号：US20130338727A1
公开(公告)日：2013-12-19
申请号：US13894348
申请日：2013-05-14
发明人： Eric A. Mokelke , Shibaji Shome , Guy Alvarez , Harlan Bos , Kenneth Martin Stein , John D. Hatlestad
IPC分类号： A61N1/36
CPC分类号： A61N1/3606 , A61B5/1116 , A61B5/1118 , A61B5/4836 , A61B5/686 , A61B2560/0209 , A61N1/36117 , A61N1/36139 , A61N1/3615 , A61N1/36167
摘要： Some embodiments, by way of example, provide a system, comprising a posture change detector configured to detect a posture transition indicative of an increased risk of syncope, and a neural stimulator configured to deliver a neural stimulation therapy. The neural stimulator may include a syncope avoidance module configured to respond to a detected posture transition by temporarily overriding the neural stimulation therapy to ameliorate the risk of increased syncope.
摘要翻译： 作为示例，一些实施例提供了一种系统，其包括姿态变化检测器，其被配置为检测指示晕厥风险增加的姿势转换，以及被配置为递送神经刺激治疗的神经刺激器。 神经刺激器可以包括晕厥避免模块，其被配置为通过暂时超越神经刺激疗法来应答检测到的姿势转变，以改善晕厥增加的风险。
-
3.发明申请公开(公告)号：US20180178018A1
公开(公告)日：2018-06-28
申请号：US15847435
申请日：2017-12-19
CPC分类号： A61N1/3787 , A61N1/0563 , A61N1/37211 , A61N1/37288 , A61N1/37512 , A61N1/3756
摘要： Implantable medical device systems and methods of use including an implantable first medical device having a lead with a transducer thereon and an implantable second medical device having a receiver for receiving energy emitted by the transducer. The lead may be placed in an internal thoracic vein, and other locations may be used as well. The implantable second medical device may be placed in or on the heart or an associated blood vessel.
-
4.发明授权Systems and methods to reduce syncope risk during neural stimulation therapy 有权减少神经刺激治疗期间晕厥风险的系统和方法公开(公告)号：US09403007B2
公开(公告)日：2016-08-02
申请号：US13894348
申请日：2013-05-14
发明人： Eric A. Mokelke , Shibaji Shome , Guy Alvarez , Harlan Bos , Kenneth Martin Stein , John D. Hatlestad
CPC分类号： A61N1/3606 , A61B5/1116 , A61B5/1118 , A61B5/4836 , A61B5/686 , A61B2560/0209 , A61N1/36117 , A61N1/36139 , A61N1/3615 , A61N1/36167
摘要： Some embodiments, by way of example, provide a system, comprising a posture change detector configured to detect a posture transition indicative of an increased risk of syncope, and a neural stimulator configured to deliver a neural stimulation therapy. The neural stimulator may include a syncope avoidance module configured to respond to a detected posture transition by temporarily overriding the neural stimulation therapy to ameliorate the risk of increased syncope.
摘要翻译： 作为示例，一些实施例提供了一种系统，其包括姿态变化检测器，其被配置为检测指示晕厥风险增加的姿势转换，以及被配置为递送神经刺激治疗的神经刺激器。 神经刺激器可以包括晕厥避免模块，其被配置为通过暂时超越神经刺激疗法来应答检测到的姿势转变，以改善晕厥增加的风险。
-
-
-
搜索结果
4 条记录 (耗时 0.014 秒)
